< 回列表
彭夢婷
- Attending physician, Division of Hematology-Oncology, Linkou Chang Gung Memorial Hospital
Optimizing the treatment sequence in HR+/HER2- mBC after ET resistance, focusing on the PI3K AKT mTOR pathway
| 角色 | 講師 |
| 日期時間 | 05/02 14:00 - 15:00 |
| 地點 | 701C |
學歷 / 訓練
2010, M.D., Chang Gung Medical College, Chang Gung Universerty, Taiwan
2022, M.S., Clinical Informatics and Medical Stastistics Research Center, Chang Gung Universerty, Taiwan
2022, Visiting Scholar of Academic Medicine Program, St Edmull Hall, Oxford University, United Kindom
專業與研究經歷
Consultant of breast cancer and hereditary breast cancer syndrome, one of the directors of Taiwan Society of Immunotherapy for Cancer, and the chairman of Chemotherapy Safety Committee of Cancer Center in Linkou Chang Gung Memorial Hospital.
Member of “Precision Medicine Multidisciplinary Team”, “Immuno-oncology Center of Excellence”, and “Breast Cancer Multidisciplinary Team” at the institute since 2015.